C. R. Bard Inc. - redOrbit

News - C. R. Bard Inc.

Trial Data Demonstrates Bard LIFESTENTÂ® Vascular Stent Is Superior to Angioplasty for Lesions in Superficial Femoral Artery and Proximal Popliteal Artery

2010-06-15 08:00:00

MURRAY HILL, N.J., June 15 /PRNewswire/ -- C. R. Bard, Inc.

NEJM Publishes Trial Results Demonstrating Bard FLAIR(R) Endovascular Stent Graft is Superior to Balloon Angioplasty for Failing Dialysis Grafts

2010-02-10 17:00:00

MURRAY HILL, N.J., Feb. 10 /PRNewswire-FirstCall/ -- C. R. Bard, Inc.

Reportlinker Adds Brachytherapy Report

2009-09-08 10:21:00

NEW YORK, Sept. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Brachytherapy http://www.reportlinker.com/p0131245/Brachytherapy.html This report analyzes the Global Market for Brachytherapy in Millions of US$.

JAMA Publishes Study Results on Efficacy of the Bard Agento(R) I.C. Silver-Coated Endotracheal Tube in Preventing Ventilator-Associated Pneumonia

2008-08-20 09:01:30

C. R. Bard, Inc. (NYSE: BCR) today announced the publication of the North American Silver-Coated Endotracheal Tube (NASCENT) clinical study results in the August 20, 2008 edition of the Journal of the American Medical Association (JAMA).

Bard Signs Agreement to Acquire Specialized Health Products International, Inc.

2008-03-10 18:01:01

C. R. Bard, Inc. (NYSE: BCR) today announced that it has signed an agreement to acquire all the outstanding shares of Specialized Health Products International, Inc. (OTCBB: SHPI) for a purchase price of $1.00 per share in cash, totaling approximately $68 million.

More News (6 articles) »

News - C. R. Bard Inc.

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health